Emergence of new symptoms in experiences of daily living in early Parkinson’s disease
Objective: To explore the utility of assessing emergence of new symptoms (ES) impacting the daily experiences of patients with early Parkinson’s disease (PD) in relation…Safety and efficacy of unilateral subthalamotomy by magnetic resonance guided focused ultrasound (MRgFUS) in asymmetrical Parkinson’s disease (PD).
Objective: To report motor and nonmotor outcomes after unilateral MRgFUS subthalamotomy for the treatment of asymmetrical PD. Background: The development of MRgFUS as a minimally…Satisfaction of Parkinson patients, caregivers and clinicians after STN-DBS and its predictors
Objective: To evaluate and compare patients’ and caregivers’ satisfaction with subthalamic nucleus (STN)-DBS and to identify preoperative indicators, which can prove valuable in defining postoperative…A Review of Electronic Devices to Track Medication Adherence in Parkinson’s Disease
Objective: The current study set out to compare existing electronic devices (EDs) for tracking medication adherence (MA) and to provide a framework for device selection…Building a Data Base for Automatic Speech Recognition in Parkinson’s disease (PD)
Objective: Describe the rationale and process for acquiring speech data to contribute to increasing accessibility to speech recognition for patients with PD. Background: Disordered speech…Preliminary validation of an educational handbook for Parkinson’s disease patients in Brazil
Objective: To describe the development and preliminary validation of an educational handbook for Parkinson’s disease (PD) patients. Background: PD is a progressive, chronic and heterogeneous…Patient-Reported Impact of Standard-of-Care: Change in Symptoms Following Dopamine Initiation and Deep Brain Stimulation
Objective: The goal of this study was to describe changes in patient-reported symptoms following initiation of standard-of-care treatment strategies in Parkinson’s disease (PD). Background: A…The role of community engagement and involvement in Parkinson’s disease research: a case study from Africa
Objective: Using a case study from Africa to understand the potential role of community engagement and involvement (CEI) in future research on Parkinson’s disease (PD).…Evaluating Patients’ Preferences for Parkinson’s Disease Treatments
Objective: To identify patients’ preferences for attributes of oral medications that are added to levodopa or levodopa/carbidopa (LD/CD) regimens to reduce OFF-time for Parkinson’s disease…Modeling of the Placebo Response in Parkinson’s Disease
Objective: The objective of this study was to investigate the predictability of the placebo response in Parkinson's disease (PD) subjects participating in a randomized clinical…
- « Previous Page
- 1
- …
- 284
- 285
- 286
- 287
- 288
- …
- 338
- Next Page »